The optimal 18F-Fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth.

Cite

APA
Gertsenshteyn, I., Epel, B., Ahluwalia, A., Kim, H., Fan, X., Barth, E., … Chen, C.-T. (2022). The optimal 18F-Fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth. European Journal of Nuclear Medicine and Molecular Imaging.

Chicago/Turabian
Gertsenshteyn, Inna, Boris Epel, Amandeep Ahluwalia, Heejong Kim, Xiaobing Fan, Eugene Barth, Marta Zamora, et al. “The Optimal 18F-Fluoromisonidazole PET Threshold to Define Tumor Hypoxia in Preclinical Squamous Cell Carcinomas Using pO2 Electron Paramagnetic Resonance Imaging as Reference Truth.” European Journal of Nuclear Medicine and Molecular Imaging (2022).

MLA
Gertsenshteyn, Inna, et al. “The Optimal 18F-Fluoromisonidazole PET Threshold to Define Tumor Hypoxia in Preclinical Squamous Cell Carcinomas Using pO2 Electron Paramagnetic Resonance Imaging as Reference Truth.” European Journal of Nuclear Medicine and Molecular Imaging, 2022.